IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Jan 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-01-02

Reporting Person: CROOKE STANLEY T (Director, Chairman and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-02	Employee Stock Option (right to buy)	$53.77	A	143400	Acquired	2026-01-01	Common Stock (143400)	Direct
2019-01-02	Employee Stock Option (right to buy)	$53.77	A	12000	Acquired	2026-01-01	Common Stock (12000)	Indirect

Footnotes

F1: Grant of 01/02/2019 to reporting person or reporting person's wife (as indicated) of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 01/02/2020. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments over the next 3 years. Following this transaction, the option was exercisable as to 0 on 01/02/2019.